Jazz Pharmaceuticals PLC - 00B4Q5ZN4

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q1 2024 · Compare: Q4 2023
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
Swedbank AB History New 1,036,743 124,845 1.09% 1 +1,036,743 New Q1 2024 May 15, 2024
DnB Asset Management AS History Reduced 9,693 1,167 0.01% 0.03% 2 -42,719 -81.51% Q1 2024 Apr 12, 2024